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Acute respiratory failure (ARF) is deﬁned as a sudden malfunction in the ability of respiratory system to
maintain adequate gas exchange. Acute hypercapnic respiratory failure develops as a result of ventilation
deﬁciency and it is deﬁned as an increase of PaCO2 above 45 mmHg. Myasthenia Gravis (MG) is a
sporadically developing auto-immune deﬁciency where the neuro-muscular transmission is affected and
it is one of the important reasons for neurologically-induced respiratory distress. Here, we report a case
of a 75-year-old male patient previously undiagnosed MG, who presented with ARF. MG is not a common
entity that we encounter daily. Patients on occasions may present to the emergency department because
of acute exacerbation. Though most of them were known cases, we should be aware of some unrecog-
nized cases and should consider MG as a differential diagnosis for patients with acute respiratory failure.
Copyright © 2016 The Emergency Medicine Association of Turkey. Production and hosting by Elsevier
B.V. on behalf of the Owner. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
ARF, which is deﬁned as a sudden malfunction in the ability of
the respiratory system to maintain adequate gas exchange, can be
collected under two titles, namely acute hypoxemic respiratory
failure characterized by disruption in the primary oxygenation
condition (Type 1), and hypercapnic respiratory failure deﬁned as a
sudden increase in the carbon dioxide pressure. Type 2 respiratory
failure develops as a result of ventilation deﬁciency, which is deﬁned
as PaCO2 increasing above 45 mmHg and accompanying hyper-
capnia. Normal pH (7.35) and bicarbonate level being high in spite
of hypercapnia indicate that respiratory failure is chronic in nature.
The reason for this is generally outside of the lungs and it could be
brain stem respiratory center depression, upper motor neuron,
anterior horn cell, neuromuscular intersection, respiratory muscles,
respiratory nerve diseases, rib cage deformities or upper respiratory
tract obstruction.1e4 MG is a sporadically developing auto-immune
deﬁciency where neuromuscular transmission is affected and it is
one of the important reasons for neurologically-induced respiratory
distress. In approximately 21% of the cases the age of onset is aboveKonya, Turkey. Tel.: þ90
.
ncy Medicine Association of
e Association of Turkey. Productio
ons.org/licenses/by-nc-nd/4.0/).60 and 30% of these develop bulbar or respiratory muscle weakness.
Myasthenic Crisis (MC) is observed in approximately 15e20% of MG
patients.5e7 If the initial diagnosis of MG is delayed or prevention of
situations in which MC can be observed in patients diagnosed with
MG is delayed, these patients may present with acute respiratory
failure causing hypercapnia requiring intubation. Here we present a
case of previously undiagnosed MG patient who presented with
acute respiratory failure.2. Case report
A 75-year-old male patient, whose general condition had
quickly deteriorated despite oral medical treatment, had ﬁrst
presented to a center with complaints of high fever, cough and sore
throat and was diagnosed with upper respiratory tract infection.
He was later brought to the emergency department with dyspnea
and mental fog. On physical examination, the general condition of
the patient was found to be moderate-poor, his blood pressure was
140/100 mm Hg, his pulse was 109/min and his temperature was
measured as 38.4 C, and his mental situation was drowsiness. PA
chest x-ray and Thorax CT of the patient performed for the deﬁn-
itive diagnosis revealed normal ﬁndings. Arterial blood gas (ABG)
analysis demonstrated PaO2: 30 mmHg; PaCO2: 60 mmHg and pH:
7.27 with a FiO2 of 40%. Rapid-sequence intubation was started
with an 8-mm endotracheal tube in the emergency department. He
was transferred to the respiratory intensive care unit (ICU) forn and hosting by Elsevier B.V. on behalf of the Owner. This is an open access article
H.H. Kozak et al. / Turkish Journal of Emergency Medicine 16 (2016) 80e82 81mechanical ventilation. Mechanical ventilation was started on
assist control (AC) mode of 16 breaths/minute with a tidal volume
of 600 mL (predicted body weight 60 kg), with a 100% FiO2, trigger;
0.2 lit/min and a PEEP of 5 mmHg. The patient, responded to the
administered antibiotic treatment begun due to high levels of fever,
leukocytosis of 23000/mL (4000e10000) and CRP: 50 mg/L
(0e5 mg/L) detected during his follow-up. On the ﬁrst day of ICU
his blood gases improved, so the ventilator mode was changed to
synchronized intermittent mandatory ventilation (SIMV) and
pressure support (PS) (SIMV þ PS) in following initial setting; tidal
volume 550 mL, respiratory rate: 10/min, FiO2: 0.4e0.6. PEEP:
5 mmHg, PS: 15 mmHg and trigger: 2 lit/min. Later on, PS and
respiratory rate were gradually decreased for the next two days
and ﬁnally ventilator mode was changed to pressure support
ventilation (PSV) with a 8 mmHg PS. On the third day of ICU his
blood gases had reached normal limits, hence he was ﬁrst
disconnected from the mechanical ventilator and then extubated
with a simple weaning and put on non-invasive ventilation (NIV). A
progressive increase was observed in the PaCO2 values on the
follow-up of ABG and hence the patient was placed on mechanical
ventilator support after having been intubated again. The patient
was evaluated and a neurology consultation required to research
the possible neurological reasons that may cause hypoventilation,
because the anamnesis, physical examination and the laboratory
ﬁndings were not compatible with Obstructive Pulmonary Disease
(COPD). The conscious patient was intubated and connected to the
mechanical ventilator, and there was no spontaneous respiratory
activity and the mechanical ventilator was producing controlled
inspiration. Neurological examination ﬁndings were normal except
for bilateral hemiptosis, and minimal restriction in the eye move-
ments in all four directions. It was learnt from the anamnesis ob-
tained that the patient had complaints of weakness, inability, easy
exhaustibility, occasional diplopia and chewing difﬁculty, and had
presented to hospitals many times but given symptomatic treat-
ments. He had also been diagnosed with COPD after presenting
with complaints of dyspnea and its treatment discontinued 5
months ago after being told he didn't have COPD. For the diagnosis
of MG, 0.5 mg Neostigmine Methylsulphate was administered
intramuscularly to the patient, who was suspected to have MG
from the anamnesis and examination ﬁndings. Spontaneous res-
piratory activity was observed after 15 min and the mechanical
ventilator begun performing assisted inspiration. Although the
arranged pressure support of the ventilator was the same, the tidal
volumes of the patient increased from approximately 200 mL/m to
330 mL/m. After about 45 min, spontaneous respiratory activity
stopped and the mechanical ventilator begun performing
controlled inspiration again. Motor and sensory nerve conductions
and muscle responses obtained with repetitive excitations were
determined to be normal on the electromyoneurography per-
formed at the bedside. The level of acetylcholine receptor antibody
(AChR Ab) level obtained from the patient was determined as
205 nmol/L (>0.40 positive). With the diagnosis of MG, pyrido-
stigmine bromide 180 mg/day and 0.4 mg/kg/day intravenous
immunoglobulin (IVIG) were administered to the patient for 5
days. Serial blood gas analysis control was performed for the pa-
tient and the weaning process was performed successfully. At the
end of the 5th day treatment with pyridostigmine bromide 180mg/
day and azathioprine 100 mg/day was arranged for the patient
whose complaints had disappeared almost completely and dis-
charged for outpatient follow-up.
3. Discussion
MG is an autoimmune disease of the neuromuscular junction,
which results from presence of postsynaptic acetylcholinereceptor antibody (IgG). It is characterized by skeletal muscle
weakness and easy fatigability and has a chronic course with
remission and exacerbation. The skeletal muscle weakness
including a single group of muscle may be asymmetric or
generalized. It typically decreases with relaxation and increases
with effort. MC is one of the important and common complica-
tions in the natural history of myasthenia gravis. MC may be
deﬁned as respiratory failure or delayed postoperative extubation
for more than 24 h resulting from myasthenic weakness. MC re-
sults from weakness of the upper airway muscles leading to
obstruction and aspiration, weakness of respiratory muscles
leading to reduced tidal volumes or from weakness of both
muscle groups. MC is observed frequently within the ﬁrst two
years following the onset of the disease. One ﬁfth of the patients
may experience MC episodes during the ﬁrst years following
onset.8 MC may be seen in 12e16% of the patients in their life
time. It has been reported commonly in patients with generalized
MG. The occurrence of respiratory insufﬁciency without gener-
alized weakness in patients is rare.9 The common precipitating
factors for MC include respiratory infections, aspiration, sepsis,
surgical procedures, rapid tapering of immune modulation agents,
starting corticosteroids treatment, exposure to drugs [antibiotics
(aminoglycosides, erythromycin and azithromycin), cardiac drugs
(beta-blockers, procainamide, and quinidine), and magnesium]
that may increase myasthenic weakness and pregnancy. Further-
more, MC can occur spontaneously as part of the natural history
of MG itself.
In the present case, there was no evidence of a hypoxemic
respiratory failure including deﬁnite inﬁltrations, edema, effusion
or pneumothorax on chest X-ray. In addition, we did not observe
any ﬁnding of pulmonary thromboembolism on the thoracic CT
scan and intra-cardiac shunting or congestive heart failure on the
echocardiography. We excluded the drugs and trauma that could
cause respiratory failure. The electrolyte levels were normal.
Considering a neuromuscular disorder clinically particular MG,
unless there are other neurological symptoms such as ocular or
bulbar symptoms, its diagnosis is very difﬁcult. MC must be
considered in patients who need ventilator support with ARF, and
tests required for MG diagnosis must be performed. These pa-
tients should be evaluated in terms of edrophonium or pyrido-
stigmine tests, AChR Ab levels, and additional electrophysiological
studies. Based on these results, we investigated the possibility of a
neuromuscular disease, especially MG. In our case, the sponta-
neous respiration response and the increase in tidal volume
response are contributed to the pyridostigmine injection admin-
istered under intensive care conditions. The AChR Ab level was
found to be too high. Today, in modern intensive care conditions,
the death rate from MC is less than 5%.10
This case report raises many interesting points. It highlights the
importance of considering neuromuscular disorders in cases of
unexplained respiratory failure in an acute setting. MG is not a
common entity that we encounter daily. Patients, on occasions,
may present to the emergency department because of acute
exacerbation. Moreover, infection is a common cause for exacer-
bation of MG as in our patient. As in our case, cases of delayed MG
diagnosis may present with MC. In patients admitted to the
emergency department with ARF, respiratory failure may be the
ﬁrst symptoms of MG. MG and MC must be considered especially
in patients who are diagnosed with Type 2 respiratory failure, who
need ventilator support, whose duration of stay on the ventilator is
prolonged despite suitable treatment and/or who cannot be
separated from the ventilator. With a detailed anamnesis, by sus-
pecting MG and MC and with suitable medical approach, the
deﬁnitive diagnosis can be made for the patients and this poten-
tially fatal situation can be treated successfully.
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